183 related articles for article (PubMed ID: 15095125)
1. [The role of defensins in the pathogenesis of chronic-inflammatory bowel disease].
Schmid M; Fellermann K; Wehkamp J; Herrlinger K; Stange EF
Z Gastroenterol; 2004 Apr; 42(4):333-8. PubMed ID: 15095125
[TBL] [Abstract][Full Text] [Related]
2. Defensin-immunology in inflammatory bowel disease.
Wehkamp J; Stange EF; Fellermann K
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
[TBL] [Abstract][Full Text] [Related]
3. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
Wehkamp J; Schmid M; Fellermann K; Stange EF
J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
[TBL] [Abstract][Full Text] [Related]
4. Defensins and inflammation: the role of defensins in inflammatory bowel disease.
Ramasundara M; Leach ST; Lemberg DA; Day AS
J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
6. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
[TBL] [Abstract][Full Text] [Related]
7. Crohn's disease: a defensin deficiency syndrome?
Fellermann K; Wehkamp J; Herrlinger KR; Stange EF
Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):627-34. PubMed ID: 12840673
[TBL] [Abstract][Full Text] [Related]
8. [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance].
Stange EF; Schmid M; Fellermann K; Wehkamp J
Praxis (Bern 1994); 2005 Sep; 94(37):1429-32. PubMed ID: 16193905
[TBL] [Abstract][Full Text] [Related]
9. Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease.
Wehkamp J; Koslowski M; Wang G; Stange EF
Mucosal Immunol; 2008 Nov; 1 Suppl 1():S67-74. PubMed ID: 19079235
[TBL] [Abstract][Full Text] [Related]
10. Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.
Wang G; Stange EF; Wehkamp J
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1049-57. PubMed ID: 18039087
[TBL] [Abstract][Full Text] [Related]
11. Human defensins in Crohn's disease.
Wehkamp J; Fellermann K; Stange EF
Chem Immunol Allergy; 2005; 86():42-54. PubMed ID: 15976487
[TBL] [Abstract][Full Text] [Related]
12. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
13. [Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn's disease].
Lapis K
Orv Hetil; 2010 Oct; 151(40):1645-55. PubMed ID: 20860961
[TBL] [Abstract][Full Text] [Related]
14. Alpha-defensins in the gastrointestinal tract.
Cunliffe RN
Mol Immunol; 2003 Nov; 40(7):463-7. PubMed ID: 14568393
[TBL] [Abstract][Full Text] [Related]
15. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.
Salzman NH; Underwood MA; Bevins CL
Semin Immunol; 2007 Apr; 19(2):70-83. PubMed ID: 17485224
[TBL] [Abstract][Full Text] [Related]
16. Defensins and Paneth cells in inflammatory bowel disease.
Shi J
Inflamm Bowel Dis; 2007 Oct; 13(10):1284-92. PubMed ID: 17567878
[TBL] [Abstract][Full Text] [Related]
17. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
[TBL] [Abstract][Full Text] [Related]
18. [Human beta-defensin 1: from defence to offence].
Schroeder BO; Stange EF; Wehkamp J
Z Gastroenterol; 2012 Nov; 50(11):1171-5. PubMed ID: 23150110
[TBL] [Abstract][Full Text] [Related]
19. Innate defenses of the intestinal epithelial barrier.
Müller CA; Autenrieth IB; Peschel A
Cell Mol Life Sci; 2005 Jun; 62(12):1297-307. PubMed ID: 15971105
[TBL] [Abstract][Full Text] [Related]
20. Multispecific myeloid defensins.
Lehrer RI
Curr Opin Hematol; 2007 Jan; 14(1):16-21. PubMed ID: 17133095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
